PHVS

Pharvaris N.V. Ordinary Shares (PHVS)

About Pharvaris N.V. Ordinary Shares (PHVS)

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Details

Daily high

$19.83

Daily low

$17.65

Price at open

$17.78

52 Week High

$33.00

52 Week Low

$15.00

Market cap

1.1B

Dividend yield

0.00%

Volume

25,071

Avg. volume

112,750

P/E ratio

-8.02

Pharvaris N.V. Ordinary Shares News